|
|
||||||||
Eur J Cardiothorac Surg 2006;30:793-796
© 2006 Elsevier Science NL
a Department of Thoracic Surgery, Centre Hospitalier Universitaire Grenoble, France
b Department of Thoracic Surgery, Centre Hospitalier Universitaire Le Havre, France
c Department of Thoracic Surgery, Centre Hospitalier Universitaire Cedre, France
d Department of Thoracic Surgery, Centre Hospitalier Universitaire Nice, France
e Department of Thoracic Surgery, Centre Hospitalier Universitaire Rouen, France
f Department of Thoracic Surgery, Centre Hospitalier Universitaire Laennec, Paris, France
g Department of Thoracic Surgery, Centre Hospitalier Universitaire Bordeaux, France
h Division of Thoracic Surgery, Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland
Received 11 May 2006; received in revised form 25 July 2006; accepted 21 August 2006.
* Corresponding author. Tel.: +41 21 314 24 08; fax: +41 21 314 2358. (Email: hans-beat.ris{at}chuv.ch).
Background: Incidence of perioperative in-stent thrombosis associated with myocardial infarction in patients undergoing major lung resection within 3 months of coronary stenting. Methods: Retrospective multi-institutional trial including all patients undergoing major lung resection (lobectomy or pneumonectomy) within 3 months of coronary stenting with non-drug-eluting stents between 1999 and 2004. Results: There were 32 patients (29 men and 3 women), with age ranging from 46 to 82 years. One, two or four coronary stents were deployed in 72%, 22% and 6% of the patients, respectively. The time intervals between stenting and lung surgery were <30 days, 3060 days and 6190 days in 22%, 53% and 25% of the patients, respectively. All patients had dual antiplatelet therapy after stenting. Perioperative medication consisted of heparin alone or heparin plus aspirin in 34% and 66% of the patients, respectively. Perioperative in-stent thrombosis with myocardial infarction occurred in three patients (9%) with fatal outcome in one (3%). Twenty patients underwent lung resection after 4 weeks of dual antiplatelet therapy as recommended by the ACC/AHA Guideline Update; however, two out of three perioperative in-stent thrombosis occurred in this group of patients. Conclusions: Major lung resection performed within 3 months of coronary stenting may be complicated by perioperative in-stent thrombosis despite 4 weeks of dual antiplatelet therapy after stenting as recommended by the ACC/AHA Guideline Update.
Key Words: Ischemic heart disease Coronary stenting Lobectomy Pneumonectomy Stent thrombosis
This article has been cited by other articles:
![]() |
A. K. JAFFER Perioperative management of warfarin and antiplatelet therapy Cleveland Clinic Journal of Medicine, November 1, 2009; 76(Suppl_4): S37 - S44. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. T. Newsome, R. S. Weller, J. C. Gerancher, M. A. Kutcher, and R. L. Royster Coronary Artery Stents: II. Perioperative Considerations and Management Anesth. Analg., August 1, 2008; 107(2): 570 - 590. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Chung and P. Krysiak Post-mediastinoscopy mortality due to drug-eluting stent thrombosis Eur. J. Cardiothorac. Surg., June 1, 2007; 31(6): 1149 - 1150. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |